Market Research Logo

Regenerative Medicines Market by Therapy (Cell Therapy, Gene Therapy, Immunotherapy, Tissue Engineering), Product (Cell-Based, Acellular), Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Cardiovascular, Central Nervous System), Region - Glo

Regenerative Medicines Market by Therapy (Cell Therapy, Gene Therapy, Immunotherapy, Tissue Engineering), Product (Cell-Based, Acellular), Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Cardiovascular, Central Nervous System), Region - Global Forecast to 2021

The global regenerative medicines market is expected to reach USD 49.41 billion by 2021 from USD 17.06 billion in 2016, at a CAGR of 23.7% during the period of 2016-2021. The global regenerative medicines market is segmented based on product, application, therapy, and region. The cell-based product segment is expected to register the highest growth rate in the regenerative medicines market, by product, during the forecast period. The high growth in this segment is attributed to the variety of products and technologies and rapid increase in the demand of organ transplantation due to which they are most preferred in various applications.

Based on therapy, the regenerative medicines market is segmented into cell therapy, gene therapy, immunotherapy, and tissue engineering. The cell therapy segment is expected to account for the largest share of the market in 2016. Increasing funding from various governments and private organizations for carrying out research and development activities related to various cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness regarding the benefits of stem cell therapies will drive the growth of this segment.

By application, the segments are orthopaedic & musculoskeletal spine, dermatology, CNS, cardiovascular, oncology, diabetes, and others where cardiovascular and oncology segments are growing rapidly owing to the increasing cases of cancers and cardiovascular diseases especially in the U.S. Over 60,000 stem cell transplants are performed annually globally for the treatment of oncology.

Geographically, the regenerative medicines market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising incidences of cancer, increasing government support, expanding biopharmaceutical industry, and launch of new products in the market.

The major factors contributing to the growth of the regenerative medicines market include rising regulatory approvals for cell culture-based products, increasing funding for cell-based research, and technological advancements. On the other hand, high cost of research and lack of infrastructure, especially in emerging economies, are the major factors restraining the growth of this market.

The major players in this market include Celgene Corporation (U.S.), StemCells, Inc. (U.S.), Corning Incorporated (U.S.), Organogenesis Inc. (U.S.), Acelity (KCI Licensing) (U.S.), Vertex Pharmaceuticals Incorporated (U.S.), among others.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the regenerative medicines market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the regenerative medicines market

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the regenerative medicines market

Market Development: Comprehensive information about emerging markets.

Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the regenerative medicines market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY & PRICING
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ESTIMATION
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • LUCRATIVE OPPORTUNITIES IN THE REGENERATIVE MEDICINES MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
      • REGENERATIVE MEDICINES MARKET SEGMENTATION, BY THERAPY
      • REGENERATIVE MEDICINES MARKET SEGMENTATION, BY PRODUCT
      • REGENERATIVE MEDICINES MARKET SEGMENTATION, BY APPLICATION
    • MARKET DYNAMICS
    • DRIVERS
      • GOVERNMENT AND PRIVATE FUNDING TO SUPPORT THE DEVELOPMENT OF REGENERATIVE MEDICINES PRODUCTS
      • INCREASE IN GLOBAL HEALTHCARE EXPENDITURE
      • INCREASE IN AGING POPULATION
    • RESTRAINTS
      • STRINGENT REGULATORY APPROVAL PROCESS FOR REGENERATIVE MEDICINES
      • ETHICAL ISSUES WITH THE USE OF EMBRYONIC STEM CELL FOR RESEARCH AND DEVELOPMENT
    • OPPORTUNITIES
      • RISING DEMAND FOR ORGAN TRANSPLANTATION
      • STRONG PRODUCT PIPELINE TO DRIVE THE MARKET
      • INCREASE IN R&D SPENDING
    • CHALLENGES
      • LACK OF CLEAR REGULATORY GUIDELINES
      • HIGH COSTS INCURRED IN STEM CELL PROCESSING
  • GLOBAL REGENERATIVE MEDICINES MARKET, BY PRODUCT
    • INTRODUCTION
      • Table GLOBAL REGENERATIVE MEDICINES MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
    • CELL-BASED PRODUCTS
      • Table CELL-BASED REGENERATIVE MEDICINES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
      • Table CELL-BASED REGENERATIVE MEDICINES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
      • AUTOLOGOUS CELL-BASED PRODUCTS
        • Table AUTOLOGOUS REGENERATIVE MEDICINES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
      • ALLOGENEIC CELL-BASED PRODUCTS
        • Table ALLOGENEIC REGENERATIVE MEDICINES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
    • ACELLULAR PRODUCTS
      • Table ACELLULAR REGENERATIVE MEDICINES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • GLOBAL REGENERATIVE MEDICINES MARKET, BY THERAPY
    • INTRODUCTION
      • Table GLOBAL REGENERATIVE MEDICINES MARKET, BY THERAPY, 2014-2021 (USD BILLION)
    • CELL THERAPY
      • Table CELL THERAPY MARKET, BY REGION, 2014-2021 (USD BILLION)
    • GENE THERAPY
      • Table GENE THERAPY MARKET, BY REGION, 2014-2021 (USD BILLION)
    • TISSUE ENGINEERING
      • Table TISSUE ENGINEERING MARKET, BY REGION, 2014-2021 (USD BILLION)
    • IMMUNOTHERAPY
      • Table IMMUNOTHERAPY MARKET, BY REGION, 2014-2021 (USD BILLION)
  • REGENERATIVE MEDICINES MARKET, BY APPLICATION
    • INTRODUCTION
      • Table REGENERATIVE MEDICINES MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
    • ORTHOPEDIC & MUSCULOSKELETAL SPINE
      • Table ORTHOPEDIC & MUSCULOSKELETAL SPINE MARKET, BY REGION, 2014-2021 (USD BILLION)
    • DERMATOLOGY
      • Table DERMATOLOGY MARKET, BY REGION, 2014-2021 (USD BILLION)
    • CARDIOVASCULAR
      • Table CARDIOVASCULAR MARKET, BY REGION, 2014-2021 (USD BILLION)
    • CENTRAL NERVOUS SYSTEM
      • Table CENTRAL NERVOUS SYSTEM MARKET, BY REGION, 2014-2021 (USD BILLION)
    • ONCOLOGY
      • Table ONCOLOGY MARKET, BY REGION, 2014-2021 (USD BILLION)
    • DIABETES
      • Table DIABETES MARKET, BY REGION, 2014-2021 (USD BILLION)
    • OTHERS
      • Table OTHERS MARKET, BY REGION, 2014-2021 (USD BILLION)
  • GLOBAL REGENERATIVE MEDICINES MARKET, BY REGION
    • INTRODUCTION
      • Table GLOBAL REGENERATIVE MEDICINES MARKET, BY REGION, 2014-2021 (USD BILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA REGENERATIVE MEDICINES MARKET, BY GEOGRAPHY, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA REGENERATIVE MEDICINES MARKET, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA CELL-BASED PRODUCTS MARKET, BY TYPE, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA REGENERATIVE MEDICINES MARKET, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table NORTH AMERICA REGENERATIVE MEDICINES MARKET, BY THERAPY, 2014-2021 (USD BILLION)
      • U.S.
        • Table U.S. REGENERATIVE MEDICINES MARKET, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table U.S. CELL-BASED PRODUCTS MARKET, BY TYPE, 2014-2021 (USD BILLION)
        • Table U.S. REGENERATIVE MEDICINES MARKET, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table U.S. REGENERATIVE MEDICINES MARKET, BY THERAPY, 2014-2021 (USD BILLION)
      • CANADA
        • Table CANADA REGENERATIVE MEDICINES MARKET, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table CANADA CELL-BASED PRODUCTS MARKET, BY TYPE, 2014-2021 (USD BILLION)
        • Table CANADA REGENERATIVE MEDICINES MARKET, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table CANADA REGENERATIVE MEDICINES MARKET, BY THERAPY, 2014-2021 (USD BILLION)
    • EUROPE
      • Table EUROPE REGENERATIVE MEDICINES MARKET, BY GEOGRAPHY, 2014-2021 (USD BILLION)
      • Table EUROPE REGENERATIVE MEDICINES MARKET, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table EUROPE CELL-BASED PRODUCTS MARKET, BY TYPE, 2014-2021 (USD BILLION)
      • Table EUROPE REGENERATIVE MEDICINES MARKET, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table EUROPE REGENERATIVE MEDICINES MARKET, BY THERAPY, 2014-2021 (USD BILLION)
      • GERMANY
        • Table GERMANY REGENERATIVE MEDICINES MARKET, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table GERMANY CELL-BASED PRODUCTS MARKET, BY TYPE, 2014-2021 (USD BILLION)
        • Table GERMANY REGENERATIVE MEDICINES MARKET, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table GERMANY REGENERATIVE MEDICINES MARKET, BY THERAPY, 2014-2021 (USD BILLION)
      • UK
        • Table UK REGENERATIVE MEDICINES MARKET, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table UK CELL-BASED PRODUCTS MARKET, BY TYPE, 2014-2021 (USD BILLION)
        • Table UK REGENERATIVE MEDICINES MARKET, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table UK REGENERATIVE MEDICINES MARKET, BY THERAPY, 2014-2021 (USD BILLION)
      • FRANCE
        • Table FRANCE REGENERATIVE MEDICINES MARKET, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table FRANCE CELL-BASED PRODUCTS MARKET, BY TYPE, 2014-2021 (USD BILLION)
        • Table FRANCE REGENERATIVE MEDICINES MARKET, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table FRANCE REGENERATIVE MEDICINES MARKET, BY THERAPY, 2014-2021 (USD BILLION)
      • ITALY
        • Table ITALY REGENERATIVE MEDICINES MARKET, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table ITALY CELL-BASED PRODUCTS MARKET, BY TYPE, 2014-2021 (USD BILLION)
        • Table ITALY REGENERATIVE MEDICINES MARKET, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table ITALY REGENERATIVE MEDICINES MARKET, BY THERAPY, 2014-2021 (USD BILLION)
      • SPAIN
        • Table SPAIN REGENERATIVE MEDICINES MARKET, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table SPAIN CELL-BASED PRODUCTS MARKET, BY TYPE, 2014-2021 (USD BILLION)
        • Table SPAIN REGENERATIVE MEDICINES MARKET, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table SPAIN REGENERATIVE MEDICINES MARKET, BY THERAPY, 2014-2021 (USD BILLION)
      • REST OF EUROPE (ROE)
        • Table REST OF EUROPE(ROE) REGENERATIVE MEDICINES MARKET, BY PRODUCT, 2014-2021 (USD BILLION)
        • Table REST OF EUROPE(ROE) CELL-BASED PRODUCTS MARKET, BY TYPE, 2014-2021 (USD BILLION)
        • Table REST OF EUROPE (ROE) REGENERATIVE MEDICINES MARKET, BY APPLICATION, 2014-2021 (USD BILLION)
        • Table REST OF EUROPE (ROE) REGENERATIVE MEDICINES MARKET, BY THERAPY, 2014-2021 (USD BILLION)
    • ASIA-PACIFIC
      • Table ASIA-PACIFIC REGENERATIVE MEDICINES MARKET, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table ASIA-PACIFIC CELL-BASED PRODUCTS MARKET, BY TYPE, 2014-2021 (USD BILLION)
      • Table ASIA-PACIFIC REGENERATIVE MEDICINES MARKET, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table ASIA-PACIFIC REGENERATIVE MEDICINES MARKET, BY THERAPY, 2013-2021 (USD BILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW REGENERATIVE MEDICINES MARKET, BY PRODUCT, 2014-2021 (USD BILLION)
      • Table ROW CELL-BASED PRODUCTS MARKET, BY TYPE, 2014-2021 (USD BILLION)
      • Table ROW REGENERATIVE MEDICINES MARKET, BY APPLICATION, 2014-2021 (USD BILLION)
      • Table ROW REGENERATIVE MEDICINES MARKET, BY THERAPY, 2014-2021 (USD BILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SITUATION AND TRENDS
      • NEW PRODUCT LAUNCHES
        • Table NEW PRODUCT LAUNCHES, 2013-2016
      • ACQUISITIONS
        • Table ACQUISITIONS, 2014-2016
      • REGULATORY APPROVALS
        • Table REGULATORY APPROVALS, 2013-2016
      • PARTNERSHIPS
        • Table PARTNERSHIPS, 2016
        • Table AGREEMENTS, 2013-2016
  • COMPANY PROFILE
    • INTRODUCTION
    • VERTEX PHARMACEUTICALS INCORPORATED
      • BUSINESS OVERVIEW
      • PRODUCTS/SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • CELGENE CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS/SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ACELITY (KCI LICENSING)
      • BUSINESS OVERVIEW
      • PRODUCTS/SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NUVASIVE, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS/SERVICES OFFERED
      • RECENT DEVELOPMENTS
    • ORGANOGENESIS INC.
      • BUSINESS OVERVIEW
      • PRODUCTS/SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • JAPAN TISSUE ENGINEERING CO., LTD (SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
      • BUSINESS OVERVIEW
      • PRODUCTS/SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • VERICEL CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS/SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • CYTORI THERAPEUTICS INC.
      • BUSINESS OVERVIEW
      • PRODUCTS/SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • STEMCELLS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS/SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ADVANTAGENE, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS/SERVICES OFFERED
    • MESOBLAST LTD
      • BUSINESS OVERVIEW
      • PRODUCTS/SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
  • APPENDIX
    • INSIGHTS FROM INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report